Peroxin 5 Activators are a collection of chemical compounds that indirectly facilitate the augmentation of Peroxin 5 functional activity through their influence on peroxisome proliferation and related pathways. Compounds like Bezafibrate, Clofibrate, Fenofibrate, WY-14643, Gemfibrozil, and Ciprofibrate are PPAR agonists that stimulate the peroxisome proliferator-activated receptor pathway, leading to an increase in peroxisome biogenesis. The resultant increase in the number of peroxisomes within cells necessitates enhanced protein import, a process in which Peroxin 5 is critically involved. These activators, therefore, indirectly enhance Peroxin 5 activity by raising the intracellular demand for its peroxisomal protein import function. Similarly, Pioglitazone and Rosiglitazone, by acting as PPAR gamma agonists, amplify peroxisomal proliferation, further potentiating the role of Peroxin 5.
Additionally, Leukotriene B4 and its synthetic analogs, by serving as ligands to PPARs, contribute to the activation of pathways leading to peroxisome proliferation, thereby indirectly enhancing the activity of Peroxin 5. Natural PPAR activators such as Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA), which are omega-3 fatty acids, also modulate the PPAR pathway, potentially leading to increased peroxisomal protein import demands and consequently, increased activity of Peroxin 5. Through these various signaling pathways, these chemical activators increase the functional activity of Peroxin 5 without directly affecting its expression levels, ensuring that the protein's activity is enhanced due to increased cellular demand for its function in peroxisomal protein import.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Clofibric acid | 882-09-7 | sc-203000 sc-203000A | 10 g 50 g | $24.00 $40.00 | 1 | |
Clofibric acid is a peroxisome proliferator. It activates peroxisome proliferator-activated receptor (PPAR), which can lead to an increase in peroxisomal biogenesis, indirectly necessitating greater PEX5 activity for protein import. | ||||||
Bezafibrate | 41859-67-0 | sc-204650B sc-204650 sc-204650A sc-204650C | 500 mg 1 g 5 g 10 g | $31.00 $46.00 $122.00 $204.00 | 5 | |
Bezafibrate is another PPAR agonist that, similar to clofibric acid, can increase peroxisomal proliferation and, as a consequence, may enhance PEX5-mediated transport into peroxisomes. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Pioglitazone, a thiazolidinedione, is a PPARγ agonist. Its activation of PPARγ leads to altered gene expression, potentially increasing peroxisomal protein import and indirectly enhancing PEX5 activity. | ||||||
LTB4 (Leukotriene B4) | 71160-24-2 | sc-201043 | 50 µg | $374.00 | 4 | |
Leukotriene B4 is metabolized in peroxisomes, and its presence may signal the need for increased peroxisomal function, which could upregulate PEX5 activity to meet the metabolic demand. | ||||||
Docosa-4Z,7Z,10Z,13Z,16Z,19Z-hexaenoic Acid (22:6, n-3) | 6217-54-5 | sc-200768 sc-200768A sc-200768B sc-200768C sc-200768D | 100 mg 1 g 10 g 50 g 100 g | $94.00 $210.00 $1779.00 $8021.00 $16657.00 | 11 | |
DHA is an omega-3 fatty acid that is partially metabolized in peroxisomes. Its metabolism may stimulate peroxisomal activity and thereby enhance the function of PEX5 for fatty acid transport. | ||||||
Eicosa-5Z,8Z,11Z,14Z,17Z-pentaenoic Acid (20:5, n-3) | 10417-94-4 | sc-200766 sc-200766A | 100 mg 1 g | $104.00 $431.00 | ||
EPA, another omega-3 fatty acid metabolized in peroxisomes, could increase the functional demand on PEX5 by enhancing the metabolic processes in peroxisomes. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate can induce oxidative stress, leading to an adaptive increase in peroxisomal activities to counteract the stress, which may indirectly enhance PEX5 activity. | ||||||